APO Research

APO RESEARCH · REPORT

Software as a Medical Device (SaMD)

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.

Product & engineering

Understand the product.

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.

Selected research

Market Analysis & Forecast

Global Software as a Medical Device (SaMD) Market Analysis and Forecast 2026-2032

Market perspective

SaMD is software that performs one or more medical functions. While the software may be embedded in a piece of hardware (as is often the case) it's the software itself that performs the medical function.

According to types, the most proportion of the Global Software as a Medical Device market share is Cloud-based, taking about 67.34% share of global market in 2020. The most proportion of the Global Software as a Medical Device market share is used for Monitoring and Alerting and the proportion is about 41.55% in 2020.

Report Includes

Read the full market overview

This report presents an overview of global market for Software as a Medical Device (SaMD), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Software as a Medical Device (SaMD), also provides the revenue of main regions and countries. Of the upcoming market potential for Software as a Medical Device (SaMD), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Software as a Medical Device (SaMD) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Software as a Medical Device (SaMD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Software as a Medical Device (SaMD) revenue, projected growth trends, production technology, application and end-user industry.

Software as a Medical Device (SaMD) Segment by Company

MindMaze

Medtronic

Viz.AI.

Siemens Healthcare

iSchemaView

Arterys

Adherium

Digital Diagnostics

Allscripts

Software as a Medical Device (SaMD) Segment by Type

Cloud-based

On Premise

Software as a Medical Device (SaMD) Segment by Application

Screening and Diagnosis

Monitoring and Alerting

Chronic Disease Management

Other

Software as a Medical Device (SaMD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Software as a Medical Device (SaMD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Software as a Medical Device (SaMD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Software as a Medical Device (SaMD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Software as a Medical Device (SaMD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Software as a Medical Device (SaMD) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Software as a Medical Device (SaMD) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Software as a Medical Device (SaMD) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On Premise Major Player Table 4. Global Software as a Medical Device (SaMD) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Screening and Diagnosis Major Player Table 6. Monitoring and Alerting Major Player Table 7. Chronic Disease Management Major Player Table 8. Other Major Player Table 9. Software as a Medical Device (SaMD) Industry Trends Table 10. Software as a Medical Device (SaMD) Industry Drivers Table 11. Software as a Medical Device (SaMD) Industry Opportunities and Challenges Table 12. Software as a Medical Device (SaMD) Industry Restraints Table 13. Global Software as a Medical Device (SaMD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Software as a Medical Device (SaMD) Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Software as a Medical Device (SaMD) Market Share by Region (2021-2026) Table 16. Global Software as a Medical Device (SaMD) Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Software as a Medical Device (SaMD) Market Share by Region (2027-2032) Table 18. Global Software as a Medical Device (SaMD) Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Software as a Medical Device (SaMD) Revenue Market Share by Players (2021-2026) Table 20. Global Software as a Medical Device (SaMD) Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Software as a Medical Device (SaMD) Key Players Headquarters & Area Served Table 22. Global Software as a Medical Device (SaMD) Players, Product Type & Application Table 23. Global Software as a Medical Device (SaMD) Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Software as a Medical Device (SaMD) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Software as a Medical Device (SaMD) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Software as a Medical Device (SaMD) Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Software as a Medical Device (SaMD) Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Software as a Medical Device (SaMD) Revenue Market Share by Type (2021-2026) Table 30. Global Software as a Medical Device (SaMD) Revenue Market Share by Type (2027-2032) Table 31. Global Software as a Medical Device (SaMD) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Software as a Medical Device (SaMD) Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Software as a Medical Device (SaMD) Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Software as a Medical Device (SaMD) Revenue Market Share by Application (2021-2026) Table 35. Global Software as a Medical Device (SaMD) Revenue Market Share by Application (2027-2032) Table 36. MindMaze Company Information Table 37. MindMaze Business Overview Table 38. MindMaze Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. MindMaze Software as a Medical Device (SaMD) Product Portfolio Table 40. MindMaze Recent Development Table 41. Medtronic Company Information Table 42. Medtronic Business Overview Table 43. Medtronic Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Medtronic Software as a Medical Device (SaMD) Product Portfolio Table 45. Medtronic Recent Development Table 46. Viz.AI. Company Information Table 47. Viz.AI. Business Overview Table 48. Viz.AI. Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Viz.AI. Software as a Medical Device (SaMD) Product Portfolio Table 50. Viz.AI. Recent Development Table 51. Siemens Healthcare Company Information Table 52. Siemens Healthcare Business Overview Table 53. Siemens Healthcare Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Siemens Healthcare Software as a Medical Device (SaMD) Product Portfolio Table 55. Siemens Healthcare Recent Development Table 56. iSchemaView Company Information Table 57. iSchemaView Business Overview Table 58. iSchemaView Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. iSchemaView Software as a Medical Device (SaMD) Product Portfolio Table 60. iSchemaView Recent Development Table 61. Arterys Company Information Table 62. Arterys Business Overview Table 63. Arterys Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Arterys Software as a Medical Device (SaMD) Product Portfolio Table 65. Arterys Recent Development Table 66. Adherium Company Information Table 67. Adherium Business Overview Table 68. Adherium Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Adherium Software as a Medical Device (SaMD) Product Portfolio Table 70. Adherium Recent Development Table 71. Digital Diagnostics Company Information Table 72. Digital Diagnostics Business Overview Table 73. Digital Diagnostics Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Digital Diagnostics Software as a Medical Device (SaMD) Product Portfolio Table 75. Digital Diagnostics Recent Development Table 76. Allscripts Company Information Table 77. Allscripts Business Overview Table 78. Allscripts Software as a Medical Device (SaMD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Allscripts Software as a Medical Device (SaMD) Product Portfolio Table 80. Allscripts Recent Development Table 81. North America Software as a Medical Device (SaMD) Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Software as a Medical Device (SaMD) Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Software as a Medical Device (SaMD) Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Software as a Medical Device (SaMD) Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Software as a Medical Device (SaMD) Revenue by Country (2021-2026) & (US$ Million) Table 87. North America Software as a Medical Device (SaMD) Revenue by Country (US$ Million) & (2027-2032) Table 88. Europe Software as a Medical Device (SaMD) Revenue by Type (2021-2026) & (US$ Million) Table 89. Europe Software as a Medical Device (SaMD) Revenue by Type (2027-2032) & (US$ Million) Table 90. Europe Software as a Medical Device (SaMD) Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Software as a Medical Device (SaMD) Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Software as a Medical Device (SaMD) Revenue by Country (2021-2026) & (US$ Million) Table 94. Europe Software as a Medical Device (SaMD) Revenue by Country (US$ Million) & (2027-2032) Table 95. China Software as a Medical Device (SaMD) Revenue by Type (2021-2026) & (US$ Million) Table 96. China Software as a Medical Device (SaMD) Revenue by Type (2027-2032) & (US$ Million) Table 97. China Software as a Medical Device (SaMD) Revenue by Application (2021-2026) & (US$ Million) Table 98. China Software as a Medical Device (SaMD) Revenue by Application (2027-2032) & (US$ Million) Table 99. Asia Software as a Medical Device (SaMD) Revenue by Type (2021-2026) & (US$ Million) Table 100. Asia Software as a Medical Device (SaMD) Revenue by Type (2027-2032) & (US$ Million) Table 101. Asia Software as a Medical Device (SaMD) Revenue by Application (2021-2026) & (US$ Million) Table 102. Asia Software as a Medical Device (SaMD) Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Software as a Medical Device (SaMD) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Software as a Medical Device (SaMD) Revenue by Region (US$ Million) & (2021-2026) Table 105. Asia Software as a Medical Device (SaMD) Revenue by Region (US$ Million) & (2027-2032) Table 106. SAMEA Software as a Medical Device (SaMD) Revenue by Type (2021-2026) & (US$ Million) Table 107. SAMEA Software as a Medical Device (SaMD) Revenue by Type (2027-2032) & (US$ Million) Table 108. SAMEA Software as a Medical Device (SaMD) Revenue by Application (2021-2026) & (US$ Million) Table 109. SAMEA Software as a Medical Device (SaMD) Revenue by Application (2027-2032) & (US$ Million) Table 110. SAMEA Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. SAMEA Software as a Medical Device (SaMD) Revenue by Country (2021-2026) & (US$ Million) Table 112. SAMEA Software as a Medical Device (SaMD) Revenue by Country (US$ Million) & (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Software as a Medical Device (SaMD) Image Figure 2. Global Software as a Medical Device (SaMD) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Software as a Medical Device (SaMD) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On Premise Image Figure 6. Global Software as a Medical Device (SaMD) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Software as a Medical Device (SaMD) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Screening and Diagnosis Image Figure 9. Monitoring and Alerting Image Figure 10. Chronic Disease Management Image Figure 11. Other Image Figure 12. Global Software as a Medical Device (SaMD) Market Size (US$ Million) & (2021-2032) Figure 13. Global Software as a Medical Device (SaMD) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Software as a Medical Device (SaMD) Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Software as a Medical Device (SaMD) Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Software as a Medical Device (SaMD) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Software as a Medical Device (SaMD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Software as a Medical Device (SaMD) Revenue Market Share by Type (2021-2032) Figure 20. Global Software as a Medical Device (SaMD) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Software as a Medical Device (SaMD) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Software as a Medical Device (SaMD) Revenue Market Share by Application (2021-2032) Figure 23. North America Software as a Medical Device (SaMD) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032) Figure 25. North America Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032) Figure 26. North America Software as a Medical Device (SaMD) Revenue Share by Country (2021-2032) Figure 27. United States Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Software as a Medical Device (SaMD) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032) Figure 32. Europe Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032) Figure 33. Europe Software as a Medical Device (SaMD) Revenue Share by Country (2021-2032) Figure 34. Germany Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Software as a Medical Device (SaMD) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032) Figure 44. China Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032) Figure 45. Asia Software as a Medical Device (SaMD) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032) Figure 47. Asia Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032) Figure 48. Asia Software as a Medical Device (SaMD) Revenue Share by Region (2021-2032) Figure 49. Japan Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Software as a Medical Device (SaMD) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032) Figure 57. SAMEA Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032) Figure 58. SAMEA Software as a Medical Device (SaMD) Revenue Share by Country (2021-2032) Figure 59. Brazil Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Software as a Medical Device (SaMD) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On Premise
Applications
  • Screening and Diagnosis
  • Monitoring and Alerting
  • Chronic Disease Management
  • Other
Companies covered
  • MindMaze
  • Medtronic
  • Viz.AI.
  • Siemens Healthcare
  • iSchemaView
  • Arterys
  • Adherium
  • Digital Diagnostics
  • Allscripts

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Software as a Medical Device (SaMD) Market by Type
  3. 1.2.1 Global Software as a Medical Device (SaMD) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On Premise
  6. 1.3 Software as a Medical Device (SaMD) Market by Application
  7. 1.3.1 Global Software as a Medical Device (SaMD) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Screening and Diagnosis
  9. 1.3.3 Monitoring and Alerting
  10. 1.3.4 Chronic Disease Management
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Software as a Medical Device (SaMD) Market Dynamics
  1. 2.1 Software as a Medical Device (SaMD) Industry Trends
  2. 2.2 Software as a Medical Device (SaMD) Industry Drivers
  3. 2.3 Software as a Medical Device (SaMD) Industry Opportunities and Challenges
  4. 2.4 Software as a Medical Device (SaMD) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Software as a Medical Device (SaMD) Market Perspective (2021-2032)
  2. 3.2 Global Software as a Medical Device (SaMD) Growth Trends by Region
  3. 3.2.1 Global Software as a Medical Device (SaMD) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Software as a Medical Device (SaMD) Market Size by Region (2021-2026)
  5. 3.2.3 Global Software as a Medical Device (SaMD) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Software as a Medical Device (SaMD) Revenue by Players
  2. 4.1.1 Global Software as a Medical Device (SaMD) Revenue by Players (2021-2026)
  3. 4.1.2 Global Software as a Medical Device (SaMD) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Software as a Medical Device (SaMD) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Software as a Medical Device (SaMD) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Software as a Medical Device (SaMD) Key Players Headquarters & Area Served
  7. 4.4 Global Software as a Medical Device (SaMD) Players, Product Type & Application
  8. 4.5 Global Software as a Medical Device (SaMD) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Software as a Medical Device (SaMD) Market CR5 and HHI
  11. 4.6.3 2025 Software as a Medical Device (SaMD) Tier 1, Tier 2, and Tier 3
5 Software as a Medical Device (SaMD) Market Size by Type
  1. 5.1 Global Software as a Medical Device (SaMD) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
  3. 5.3 Global Software as a Medical Device (SaMD) Revenue Market Share by Type (2021-2032)
6 Software as a Medical Device (SaMD) Market Size by Application
  1. 6.1 Global Software as a Medical Device (SaMD) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
  3. 6.3 Global Software as a Medical Device (SaMD) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 MindMaze
  2. 7.1.1 MindMaze Company Information
  3. 7.1.2 MindMaze Business Overview
  4. 7.1.3 MindMaze Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 MindMaze Software as a Medical Device (SaMD) Product Portfolio
  6. 7.1.5 MindMaze Recent Developments
  7. 7.2 Medtronic
  8. 7.2.1 Medtronic Company Information
  9. 7.2.2 Medtronic Business Overview
  10. 7.2.3 Medtronic Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Medtronic Software as a Medical Device (SaMD) Product Portfolio
  12. 7.2.5 Medtronic Recent Developments
  13. 7.3 Viz.AI.
  14. 7.3.1 Viz.AI. Company Information
  15. 7.3.2 Viz.AI. Business Overview
  16. 7.3.3 Viz.AI. Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Viz.AI. Software as a Medical Device (SaMD) Product Portfolio
  18. 7.3.5 Viz.AI. Recent Developments
  19. 7.4 Siemens Healthcare
  20. 7.4.1 Siemens Healthcare Company Information
  21. 7.4.2 Siemens Healthcare Business Overview
  22. 7.4.3 Siemens Healthcare Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Siemens Healthcare Software as a Medical Device (SaMD) Product Portfolio
  24. 7.4.5 Siemens Healthcare Recent Developments
  25. 7.5 iSchemaView
  26. 7.5.1 iSchemaView Company Information
  27. 7.5.2 iSchemaView Business Overview
  28. 7.5.3 iSchemaView Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 iSchemaView Software as a Medical Device (SaMD) Product Portfolio
  30. 7.5.5 iSchemaView Recent Developments
  31. 7.6 Arterys
  32. 7.6.1 Arterys Company Information
  33. 7.6.2 Arterys Business Overview
  34. 7.6.3 Arterys Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Arterys Software as a Medical Device (SaMD) Product Portfolio
  36. 7.6.5 Arterys Recent Developments
  37. 7.7 Adherium
  38. 7.7.1 Adherium Company Information
  39. 7.7.2 Adherium Business Overview
  40. 7.7.3 Adherium Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Adherium Software as a Medical Device (SaMD) Product Portfolio
  42. 7.7.5 Adherium Recent Developments
  43. 7.8 Digital Diagnostics
  44. 7.8.1 Digital Diagnostics Company Information
  45. 7.8.2 Digital Diagnostics Business Overview
  46. 7.8.3 Digital Diagnostics Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Digital Diagnostics Software as a Medical Device (SaMD) Product Portfolio
  48. 7.8.5 Digital Diagnostics Recent Developments
  49. 7.9 Allscripts
  50. 7.9.1 Allscripts Company Information
  51. 7.9.2 Allscripts Business Overview
  52. 7.9.3 Allscripts Software as a Medical Device (SaMD) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Allscripts Software as a Medical Device (SaMD) Product Portfolio
  54. 7.9.5 Allscripts Recent Developments
8 North America
  1. 8.1 North America Software as a Medical Device (SaMD) Revenue (2021-2032)
  2. 8.2 North America Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
  3. 8.2.1 North America Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
  4. 8.2.2 North America Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
  5. 8.3 North America Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
  6. 8.4 North America Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
  7. 8.4.1 North America Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
  8. 8.4.2 North America Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
  9. 8.5 North America Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
  10. 8.6 North America Software as a Medical Device (SaMD) Revenue by Country
  11. 8.6.1 North America Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
  13. 8.6.3 North America Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Software as a Medical Device (SaMD) Revenue (2021-2032)
  2. 9.2 Europe Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
  5. 9.3 Europe Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
  9. 9.5 Europe Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Software as a Medical Device (SaMD) Revenue by Country
  11. 9.6.1 Europe Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Software as a Medical Device (SaMD) Revenue (2021-2032)
  2. 10.2 China Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
  3. 10.2.1 China Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
  4. 10.2.2 China Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
  5. 10.3 China Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
  6. 10.4 China Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
  7. 10.4.1 China Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
  8. 10.4.2 China Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
  9. 10.5 China Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Software as a Medical Device (SaMD) Revenue (2021-2032)
  2. 11.2 Asia Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
  5. 11.3 Asia Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
  9. 11.5 Asia Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Software as a Medical Device (SaMD) Revenue by Country
  11. 11.6.1 Asia Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Software as a Medical Device (SaMD) Revenue (2021-2032)
  2. 12.2 SAMEA Software as a Medical Device (SaMD) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Software as a Medical Device (SaMD) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Software as a Medical Device (SaMD) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Software as a Medical Device (SaMD) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Software as a Medical Device (SaMD) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Software as a Medical Device (SaMD) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Software as a Medical Device (SaMD) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Software as a Medical Device (SaMD) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Software as a Medical Device (SaMD) Revenue by Country
  11. 12.6.1 SAMEA Software as a Medical Device (SaMD) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Software as a Medical Device (SaMD) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Software as a Medical Device (SaMD) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research